Amalgamated Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,817
| Closed | -$29K | – | 3163 |
|
|
2024
Q1 | $29K | Sell |
1,817
-3,555
| -66% | -$54.7K | ﹤0.01% | 2017 |
|
|
2023
Q4 | $87K | Sell |
5,372
-469
| -8% | -$5.98K | ﹤0.01% | 2049 |
|
|
2023
Q3 | $74K | Hold |
5,841
| – | – | ﹤0.01% | 2105 |
|
|
2023
Q2 | $82K | Buy |
5,841
+241
| +4% | +$3.45K | ﹤0.01% | 2138 |
|
|
2023
Q1 | $87K | Sell |
5,600
-713
| -11% | -$11.9K | ﹤0.01% | 2111 |
|
|
2022
Q4 | $103K | Buy |
6,313
+152
| +2% | +$2.47K | ﹤0.01% | 2124 |
|
|
2022
Q3 | $114K | Buy |
6,161
+31
| +0.5% | +$486 | ﹤0.01% | 2093 |
|
|
2022
Q2 | $81K | Sell |
6,130
-66
| -1% | -$728 | ﹤0.01% | 2257 |
|
|
2022
Q1 | $57K | Buy |
+6,196
| New | +$52.7K | ﹤0.01% | 2418 |
|
|
2021
Q4 | – | Sell |
-6,769
| Closed | -$230K | – | 2182 |
|
|
2021
Q3 | $230K | Sell |
6,769
-401
| -6% | -$12.8K | ﹤0.01% | 1946 |
|
|
2021
Q2 | $262K | Buy |
7,170
+1,691
| +31% | +$65.5K | ﹤0.01% | 1943 |
|
|
2021
Q1 | $246K | Sell |
5,479
-477
| -8% | -$22.2K | 0.01% | 1367 |
|
|
2020
Q4 | $340K | Buy |
5,956
+137
| +2% | +$8.12K | 0.01% | 1169 |
|
|
2020
Q3 | $299K | Sell |
5,819
-167
| -3% | -$8.18K | 0.01% | 1114 |
|
|
2020
Q2 | $357K | Buy |
+5,986
| New | +$320K | 0.02% | 1012 |
|
|
2020
Q1 | – | Sell |
-3,687
| Closed | -$229K | – | 1803 |
|
|
2019
Q4 | $229K | Buy |
+3,687
| New | +$175K | ﹤0.01% | 1569 |
|
Other funds holding DCPH
Amalgamated Bank's DCPH Position: Q2 2024 in Review
Amalgamated Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,817 shares — an estimated $29K sold.
Amalgamated Bank first reported a position in DCPH in Q4 2019 and held it in 16 quarters. The position peaked at $357K in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Amalgamated Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Amalgamated Bank sold 1,817 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $29K.
- Amalgamated Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
- Amalgamated Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $357K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.